. 2012 Oct 30;15(2):158–165. doi: 10.1093/eurjhf/hfs165

Table 6.

Rates of angiotensin-converting enzyme, beta-blocker, and spironolactone prescribing in patients with left ventricular systolic dysfunction, categorized by study findings

Study		Any HF record^a	ACE inhibitor^b	Beta-blockers^b	Spironolactone^b
LVSD (n = 34)	Confirmed	19	10 (53%)	11 (58%)	0 (0%)
	New	15	5 (33%)	5 (33%)	0 (0%)
	Not confirmed	61	19 (31%)	23 (38%)	3 (5%)

ACE, angiotensin-converting enzyme; HF, heart failure; LVSD, left ventricular systolic dysfunction.

^aA heart failure record, specified or unspecified in general practice notes, register, or care facility records.

^bAny dose.